Dr David Meininger | Chief Business Officer
Trianni Inc

Appearances:

Day 1 Antibody Congress @ 14:50

The Trianni Mouse: best-in-class technology for human antibody discovery

Plenary

• The Trianni Mouse is the only human transgenic antibody discovery platform offering a complete heavy, kappa and lambda repertoire in a single organism.
• Sequences of the variable domain exons are human while all genetic machinery including extensively optimized promoters and enhancers are of mouse origin. Titers and class switching are extremely robust making for highly efficient lead generation.
• Additional strains in development include Plasma Ig, Autoimmune/All Epitope and a "true" Bispecific.

Dr David Meininger, Chief Business Officer, Trianni Inc